Skip to main content
. 2022 Mar 3;22:231. doi: 10.1186/s12885-022-09237-5

Fig. 2.

Fig. 2

Dichotomized risk model of NMF groups and adjusted multivariate model. PFS of merged groups with similar prognostic profiles into a high-risk group (purple, CD79B/MYD88 and BCL2/EZH2), and low-risk group (green, NOTCH2/TNAIFP3 and ‘no mutations’). NMF, non-negative matrix factorization; PFS, progression-free survival